Data gathered: October 6
Alternative Data for Bristol-Myers Squibb
About Bristol-Myers Squibb
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
| Price | $53.96 |
| Target Price | Sign up |
| Volume | 12,790,000 |
| Market Cap | $109B |
| Year Range | $39.46 - $54.2 |
| Dividend Yield | 4.45% |
| PE Ratio | 12.66 |
| Analyst Rating | 19% buy |
| Earnings Date | October 31 '24 |
| Industry | Drug Manufacturers |
In the news
 |
Wallace Advisory Group LLC Cuts Position in Bristol-Myers Squibb (NYSE:BMY)October 5 - ETF Daily News |
|
Bristol-Myers Squibb (NYSE:BMY) Position Boosted by Wright Investors Service Inc.October 5 - ETF Daily News |
|
Burns J W & Co. Inc. NY Cuts Stock Position in Bristol-Myers Squibb (NYSE:BMY)October 5 - ETF Daily News |
 |
Sanctuary Advisors LLC Invests $7.94 Million in Bristol-Myers Squibb (NYSE:BMY)October 5 - Biztoc.com |
|
Canandaigua National Bank & Trust Co. Sells 2,952 Shares of Bristol-Myers Squibb (NYSE:BMY)October 4 - ETF Daily News |
|
Czech National Bank Buys 26,718 Shares of Bristol-Myers Squibb (NYSE:BMY)October 4 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 12.2B | 7.67B | 4.53B | 1.68B | -438M | 2.070 |
| Q1 '24 | 11.9B | 7.77B | 4.09B | -11.9B | -8.69B | -4.400 |
| Q4 '23 | 11.5B | 7.19B | 4.29B | 1.76B | 4.29B | 1.590 |
| Q3 '23 | 11B | 6.93B | 4.03B | 1.93B | 4.71B | 2.000 |
| Q2 '23 | 11.2B | 7.22B | 4.01B | 2.07B | 4.44B | 1.750 |
Insider Transactions View All
| BOERNER CHRISTOPHER S. filed to buy 82,672 shares at $49.8. December 7 '23 |
| BOERNER CHRISTOPHER S. filed to buy 79,384 shares at $48.9. November 30 '23 |
| Samuels Theodore R. II filed to buy 35,500 shares at $49.8. November 21 '23 |
| Powell Ann filed to sell 27,868 shares at $61.3. August 28 '23 |
| Plenge Robert M filed to sell 6,584 shares at $61.1. August 7 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$160.29 0% | 59 |
 |
Eli Lilly and CompanyLLY |
$887.16 0% | 73 |
 |
PfizerPFE |
$28.58 0% | 49 |
 |
AstrazenecaAZN |
$77.47 0% | 51 |
 |
AbbVieABBV |
$194.29 0% | 59 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| John James |
Sep 2, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $15K - $50K |
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $15K - $50K |
Read more about Bristol-Myers Squibb (BMY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Bristol-Myers Squibb?
The Market Cap of Bristol-Myers Squibb is $109B.
What is Bristol-Myers Squibb's PE Ratio?
As of today, Bristol-Myers Squibb's PE (Price to Earnings) ratio is 12.66.
When does Bristol-Myers Squibb report earnings?
Bristol-Myers Squibb will report its next earnings on October 31 '24.
What is the current stock price of Bristol-Myers Squibb?
Currently, the price of one share of Bristol-Myers Squibb stock is $53.96.
How can I analyze the BMY stock price chart for investment decisions?
The BMY stock price chart above provides a comprehensive visual representation of Bristol-Myers Squibb's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bristol-Myers Squibb shares. Our platform offers an up-to-date BMY stock price chart, along with technical data analysis and alternative data insights.
Does BMY offer dividends to its shareholders?
Yes, Bristol-Myers Squibb (BMY) offers dividends to its shareholders, with a dividend yield of 4.45%. This dividend yield represents Bristol-Myers Squibb's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bristol-Myers Squibb in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Bristol-Myers Squibb?
Some of the similar stocks of Bristol-Myers Squibb are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.